1. |
Kowluru RA, Kowluru A, Mishra M, et al. Oxidative stress and epigenetic modifications in the pathogenesis of diabetiaretinaopathy[J]. ProgRetin Eye Res, 2015, 48: 40-61. DOI: 10.1016/j.preteyeres.2015.05.001.
|
2. |
Oh IK, Kin SW, Oh J, et al. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy[J]. Curr Eye Res, 2010, 35(12): 1116-1127. DOI: 10.3109/02713683.2010.510257.
|
3. |
Schertzer JD, Tamrakar AK, Magalhães JG, et al. NODI activators link innate immunity to insulin resistance[J]. Diabeties, 2011, 60(9): 2206-2215. DOI: 10.2337/db11-0004.
|
4. |
Zoccal KF, Sorgi CA, Hori JI, et al. Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality[J/OL]. Nat Commun, 2016, 7: 10760[2016-02-23]. https://pubmed.ncbi.nlm.nih.gov/26907476/. DOI: 10.1038/ncomms10760.
|
5. |
Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvasculardisease[J]. Diabetes, 2006, 55(9): 2401-2411. DOI: 10.2337/db05-1635.
|
6. |
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. DOI: 10.1016/S0140-6736(09)62124-3.
|
7. |
Nawaz MI, Van Raemdonck K, Mohammad G, et al. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy[J]. Exp Eye Res, 2013, 109: 67-76. DOI: 10.1016/j.exer.2013.01.008.
|
8. |
Abu El-Asrar AM, Alam K, Nawaz MI, et al. Upregulated expression of heparanase in the vitreous of patients with proliferative diabetic retinopathy originates from activated endothelial cells and leukocytes[J]. Invest Ophthalmol Vis Sci, 2015, 56(13): 8239-8247. DOI: 10.1167/iovs.15-18025.
|
9. |
Abran D, Li DY, Varma DR, et al. Characterization and ontogeny of PGE2 and PGF2 alpha receptors on retinal vasculature of the pig[J]. Prostaglandins, 1995, 50(5-6): 253-267. DOI: 10.1016/0090-6980(95)00132-8.
|
10. |
Komuro M, Kamiyama M, Furuya Y, et al. Gene and protein expression profiles of prostaglandin E2 receptor subtypes in the human corpus cavernosum[J]. Int J Impot Res, 2006, 18(3): 275-281. DOI: 10.1038/sj.ijir.3901408.
|
11. |
Oba K, Hosono K, Amano H, et al. Downregulation of the proangiogenic prostaglandin E receptor EP3 and reduced angiogenesis in a mouse model of diabetes mellitus[J]. Biomed Pharmacother, 2014, 68(8): 1125-1133. DOI: 10.1016/j.biopha.2014.10.022.
|
12. |
Sugimoto Y, Narumiya S. Prostaglandin E receptors[J]. J Biol Chem, 2007, 282(16): 11613-11617. DOI: 10.1074/jbc.R600038200.
|
13. |
Wang Y, Tao J, Yao Y. Prostaglandin E2 activates NLRP3 inflammasome in endothelial cells to promote diabetic retinopathy[J]. HormMetab Res, 2018, 50(9): 704-710. DOI: 10.1055/a-0664-0699.
|
14. |
Wang M, Wang Y, Xie T, et al. Prostaglandin E2/EP2 receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes[J]. Diabetologia, 2019, 62(2): 335-348. DOI: 10.1007/s00125-018-4755-3.
|
15. |
Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1β signaling prevents degeneration of retinal capillaries in diabetes and galactosemia[J]. Diabetes, 2007, 56(1): 224-230. DOI: 10.2337/db06-0427.
|
16. |
Devi TS, Lee I, Hüttemann M, et al. TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal muller glia under chronic hyperglycemia: implications for diabetic retinopathy[J/OL]. Exp Diabetes Res, 2012, 2012: 438238[2012-03-18]. https://pubmed.ncbi.nlm.nih.gov/22474421/. DOI: 10.1155/2012/438238.
|
17. |
Leemans JC, Cassel SL, Sutterwala FS. Sensing damage by the NLRP3 inflammasome[J]. Immunol Rev, 2011, 243(1): 151-162. DOI: 10.1111/j.1600-065X.2011.01043.x.
|
18. |
Catalioto RM, Valenti C, Maggi CA, et al. Enhanced Ca(2+) response and stimulation of prostaglandin release by the bradykinin B2 receptor in human retinal pigment epithelial cells primed with proinflammatory cytokines[J]. Biochem Pharmacol, 2015, 97(2): 189-202. DOI: 10.1016/j.bcp.2015.07.034.
|
19. |
Vande Walle L, Lamkanfi M. Pyroptosis[J]. CurrBiol, 2016, 26(13): R568-R572. DOI: 10.1016/j.cub.2016.02.019.
|
20. |
Jorfensen I, Miao EA. Pyroptotic cell death defends against intracellular pathpgens[J]. Immunol Rev, 2015, 265(1): 130-142. DOI: 10.1111/imr.12287.
|